BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 6113937)

  • 21. Major cytochrome P450 enzyme responsible for oxidation of secondary alcohols to the corresponding ketones in mouse hepatic microsomes. Oxidation of 7-hydroxy-delta8-tetrahydrocannabinol to 7-oxo-delta8-tetrahydrocannabinol.
    Matsunaga T; Kishi N; Tanaka H; Watanabe K; Yoshimura H; Yamamoto I
    Drug Metab Dispos; 1998 Oct; 26(10):1045-7. PubMed ID: 9763413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of cannabinoids on levels of acetylcholine and choline and on turnover rate of acetylcholine in various regions of the mouse brain.
    Tripathi HL; Vocci FJ; Brase DA; Dewey WL
    Alcohol Drug Res; 1987; 7(5-6):525-32. PubMed ID: 3620017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stereospecificity of the discriminative stimulus functions of the dimethylheptyl homologs of 11-hydroxy-delta 8-tetrahydrocannabinol in rats and pigeons.
    Järbe TU; Hiltunen AJ; Mechoulam R
    J Pharmacol Exp Ther; 1989 Sep; 250(3):1000-5. PubMed ID: 2550611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolism of (+)-trans-delta 8-tetrahydrocannabinol in the mouse in vitro and in vivo.
    Harvey DJ; Marriage HJ
    Drug Metab Dispos; 1987; 15(6):914-20. PubMed ID: 2893721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the effects of 11-palmitoyloxy-delta 9-tetrahydrocannabinol with delta 9-tetrahydrocannabinol and 11-hydroxy-delta 9-tetrahydrocannabinol on the hepatic microsomal drug-metabolizing enzyme system.
    Leighty EG
    Res Commun Chem Pathol Pharmacol; 1979 Sep; 25(3):525-35. PubMed ID: 116333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of systemic and intraventricular administration of cannabinoids on schedule-controlled responding in the squirrel monkey.
    Carney JM; Balster RL; Martin BR; Harris LS
    J Pharmacol Exp Ther; 1979 Sep; 210(3):399-404. PubMed ID: 113528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo metabolism of (+)-trans-delta-9-tetrahydrocannabinol in the mouse.
    Harvey DJ
    Biomed Environ Mass Spectrom; 1988 Jan; 15(2):117-22. PubMed ID: 2832023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison between the metabolism of delta 1-tetrahydrocannabinol by perfused lung and liver of rat and guinea-pig.
    Halldin MM; Isaac H; Widman M; Nilsson E; Ryrfeldt A
    Xenobiotica; 1984 Mar; 14(3):277-82. PubMed ID: 6324501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of hepatic metabolites of n-heptyl-delta-1-tetrahydrocannabinol in the mouse.
    Harvey DJ
    Xenobiotica; 1985 Mar; 15(3):187-97. PubMed ID: 2992174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An in vitro rat liver microsomal system for conjugating fatty acids to 11-hydroxy-delta 9-tetrahydrocannabinol.
    Leighty EG
    Res Commun Chem Pathol Pharmacol; 1979 Mar; 23(3):483-92. PubMed ID: 37559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological characterization of cannabinoids in the elevated plus maze.
    Onaivi ES; Green MR; Martin BR
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1002-9. PubMed ID: 2162942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of Large White Pig as an animal model for the study of cannabinoids metabolism: application to the study of THC distribution in tissues.
    Brunet B; Doucet C; Venisse N; Hauet T; Hébrard W; Papet Y; Mauco G; Mura P
    Forensic Sci Int; 2006 Sep; 161(2-3):169-74. PubMed ID: 16859848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. delta 9-Tetrahydrocannabinol decreases turnover of brain histamine.
    Oishi R; Itoh Y; Nishibori M; Saeki K
    J Pharmacol Exp Ther; 1985 Feb; 232(2):513-8. PubMed ID: 2578567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human hepatic microsomal metabolism of delta 1-tetrahydrocannabinol.
    Bornheim LM; Lasker JM; Raucy JL
    Drug Metab Dispos; 1992; 20(2):241-6. PubMed ID: 1352216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tolerance and disposition of tetrahydrocannabinol in man.
    Hunt CA; Jones RT
    J Pharmacol Exp Ther; 1980 Oct; 215(1):35-44. PubMed ID: 6256518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alterations in the pharmacokinetics of 3H-delta9-tetrahydrocannabinol in mice by bacterial endotoxin.
    Martin BR; Montgomery J; Dewey WL; Harris LS
    Drug Metab Dispos; 1978; 6(3):282-7. PubMed ID: 26549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sex difference in hepatic microsomal aldehyde oxygenase activity in different strains of mice.
    Watanabe K; Matsunaga T; Narimatsu S; Yamamoto I; Yoshimura H
    Res Commun Chem Pathol Pharmacol; 1992 Dec; 78(3):373-6. PubMed ID: 1335600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantification of Delta9-tetrahydrocannabinol and its major metabolites in meconium by gas chromatographic-mass spectrometric assay: assay validation and preliminary results of the "meconium project".
    Marchei E; Pellegrini M; Pacifici R; Palmi I; Lozano J; García-Algar O; Pichini S
    Ther Drug Monit; 2006 Oct; 28(5):700-6. PubMed ID: 17038890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delta 9-tetrahydrocannabinol increases arachidonic acid levels in guinea pig cerebral cortex slices.
    Reichman M; Nen W; Hokin LE
    Mol Pharmacol; 1988 Dec; 34(6):823-8. PubMed ID: 2849049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of in vivo liver metabolites of delta 6-tetrahydrocannabinol produced by the mouse.
    Harvey DJ; Paton WD
    Drug Metab Dispos; 1980; 8(3):178-86. PubMed ID: 6104583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.